Cinemark/$CNK

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Cinemark

Cinemark Holdings Inc is a geographically diverse operator in the motion picture exhibition industry in the United States. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rentals, and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals, and electronic video games located in some of the theatres.

Ticker

$CNK

Primary listing

NYSE

Employees

19,226

Cinemark Metrics

BasicAdvanced
$3.1B
14.05
$1.92
1.85
$0.24
1.19%

What the Analysts think about Cinemark

Analyst ratings (Buy, Hold, Sell) for Cinemark stock.

Bulls say / Bears say

J.P. Morgan upgraded Cinemark to 'overweight' from 'neutral' and raised its price target to $34, citing Cinemark’s limited economic exposure and positive long-term trends in movie theater demand (Reuters via TradingView).
Cinemark’s Q2 2025 total revenue climbed 28.1% year-over-year to $940.5 million, driven by a 27.7% increase in admissions and a 29.0% rise in concession revenue, with global attendance jumping 15.8% to 57.9 million, resulting in net income of $93.5 million (SEC).
At the end of Q2 2025, Cinemark reported $932 million in cash and a net leverage ratio of 2.2× after repricing its term loan to save $3.2 million in yearly interest, positioning the company to repay the $460 million convertible notes due August 2025 (Investing.com).
Cinemark reported an adjusted net loss of $0.32 per share for Q1 2025, wider than the consensus loss estimate of $0.16, with revenue falling 6.6% year-over-year to $540.7 million, signaling a slow start to the year (Reuters via TradingView).
Cinemark faces refinancing risk with $460 million in 4.50% convertible senior notes maturing August 15, 2025. The notes become convertible at holders’ option starting May 15, 2025, which could result in dilution or require the company to buy back the notes in cash (SEC).
Roth/MKM lowered its price target for Cinemark to $34, maintaining its Buy rating but warning of a likely weaker performance in Q3 2025 given a softer slate of film releases (Investing.com).
Data summarised monthly by Lightyear AI. Last updated on 8 Oct 2025.

Cinemark Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Cinemark Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CNK

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs